Rivaroxaban Limits Complement Activation Compared to Warfarin in Antiphospholipid Syndrome Patients with Venous Thromboembolism

Arachchillage, DJ; Mackie, IJ; Efthymiou, M; Chitolie, A; Hunt, BJ; Isenberg, D; Khamashta, M; ... Cohen, H; + view all Arachchillage, DJ; Mackie, IJ; Efthymiou, M; Chitolie, A; Hunt, BJ; Isenberg, D; Khamashta, M; Machin, S; Cohen, H; - view fewer (2015) Rivaroxaban Limits Complement Activation Compared to Warfarin in Antiphospholipid Syndrome Patients with Venous Thromboembolism. Presented at: 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL.

http://ift.tt/2E8cSAn